Our alumni are not only some of the best and brightest in the field; they are a true testament to our innovative, interdisciplinary Program. They hold positions in academia, at biotech companies, hospitals, in government research labs and in the pharmaceutical industry, and are working on truly groundbreaking research.
Itai Yanai, PhD
Assistant Professor of Biology
Technion – Institute of Technology
In 2002, Dr. Yanai became the first graduate to receive his PhD in the Bioinformatics Program. After a two year appointment as a Koshland Scholar in the Molecular Genetics Department at the Weizmann Institute of Science, Dr. Yanai went on to complete his postdoctoral training in the Molecular and Cellular Biology Department at Harvard. In his current position as Assistant Professor of Biology at Technion, he leads a research group focused on developmental gene networks and now mentors graduate students of his own.
Yaoyu Wang, PhD
Center for Cancer Computational Biology, Dana Farber Cancer Institute
Dr. Wang received his PhD in 2007 and went on to Massachusetts General Hospital to work as a Research Fellow. In 2009 he accepted a position as Group Leader and Senior Bioinformatics Analyst at the Center for Cancer Computational Biology at Dana-Farber Cancer Institute. He was recently promoted to the position of Associate Director.
Brian Abraham, PhD
Whitehead Institute for Biomedical Research
Dr. Abraham is one of our most recent graduates, and one of the first to complete the BU-NIH Graduate Partnership Program (GPP). The GPP is a special PhD program between Boston University Bioinformatics and the laboratories of the Intramural Research Program of the NIH. He’s currently working as a postdoc in the area of cellular regulation in human health and disease.
Li Li, MD, MS
Icahn School of Medicine at Mount Sinai
Dr. Li received her MS in Bioinformatics in 2003 and has held positions at Stanford University School of Medicine, UC San Diego, and Quest Diagnostics at the Nichols Institute. She has over 12 years experience in clinical research and translational bioinformatics involving genetic and clinical risk factor identification, diagnostic assay development, and new therapeutic targets discovery. Her expertise is in translational research by integrating high-throughput genomics, genetics, various molecular measurements, and electronic medical records data with over 50 peer-reviewed publications including Science Translational Medicine, PNAS, Nature Methods, Nature Biotechnology, and JASN.